- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01563146
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007
March 9, 2018 updated by: GlaxoSmithKline
Assessing the Number of Rotavirus Related Hospitalizations in 11 Hospitals in Belgium - Season 2006-2007
This study aims to collect data and assess the number of rotavirus related hospitalizations in 11 hospitals in Belgium - season 2006-2007 in order to develop proper age-cohort analysis over time.
Study Overview
Detailed Description
This retrospective study will use anonymised data, extracted from hospital databases during the period of the 1st of June 2006 until the 31st of May 2007.
IMS Health sales data will be used to provide rotavirus vaccine coverage estimates (Rotarix and Rotateq) for the Belgian population during the study period.
Any additional source of vaccine coverage status describing rotavirus vaccine uptake in the study population will also be reported.
Study Type
Observational
Enrollment (Actual)
1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children aged ≤5 years undergoing a RV detection test across 11 participating hospitals.
Description
Inclusion Criteria:
- Child aged ≤5 years;
- A stool sample has been provided for a rotavirus detection test during the study period;
- Laboratory test result of rotavirus is available.
Exclusion Criteria:
Not applicable.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group A
All children ≤ 5 years old with a rotavirus detection test (inpatient and ambulatory tests) performed during the period of June the 1st 2006 and May the 31st 2007.
|
Each participating centre will be requested to generate a coded list of all stool samples taken during the study period (June 1st 2006- May 31st 2007) and analysed for rotavirus, in children aged ≤5 years.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determination of the absolute number of rotavirus related hospitalisations in children up to five years old.
Time Frame: From June 1st 2006 up to 1 year
|
From June 1st 2006 up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Classification of patients with rotavirus hospitalisation by birth cohorts, gender, time of the event, vaccine coverage status.
Time Frame: From June 1st 2006 up to 1 year
|
From June 1st 2006 up to 1 year
|
Determination of the duration of rota-related hospitalisation for community acquired and nosocomial infection per birth cohort.
Time Frame: From June 1st 2006 up to 1 year
|
From June 1st 2006 up to 1 year
|
Evaluation of the herd effect.
Time Frame: From June 1st 2006 up to 1 year
|
From June 1st 2006 up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Standaert B, Strens D, Pereira P, Benninghoff B, Raes M. Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS). Infect Dis Ther. 2020 Dec;9(4):967-980. doi: 10.1007/s40121-020-00345-y. Epub 2020 Oct 6.
- Standaert B, Strens D, Li X, Schecroun N, Raes M. The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005-2012). Infect Dis Ther. 2016 Dec;5(4):509-524. doi: 10.1007/s40121-016-0131-0. Epub 2016 Oct 6.
- Standaert B, Strens D, Alwan A, Raes M. Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS). Infect Dis Ther. 2016 Mar;5(1):31-44. doi: 10.1007/s40121-015-0099-1. Epub 2015 Dec 31.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2016
Primary Completion (Actual)
December 31, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
March 1, 2012
First Submitted That Met QC Criteria
March 22, 2012
First Posted (Estimate)
March 26, 2012
Study Record Updates
Last Update Posted (Actual)
March 12, 2018
Last Update Submitted That Met QC Criteria
March 9, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 116311
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections, Rotavirus
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesUnited States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesJapan
-
GlaxoSmithKlineCompletedRotavirus Infection | Rotavirus VaccinesUnited States
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesPhilippines
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesPhilippines
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesBelgium
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus Gastroenteritis
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesJapan
-
GlaxoSmithKlineCompletedInfections, RotavirusDominican Republic, Honduras, Panama, Mexico, Brazil, Argentina, Colombia, Chile, Finland, Nicaragua, Peru, Venezuela
Clinical Trials on Data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance